Literature DB >> 29195547

The role of interventricular conduction delay to predict clinical response with cardiac resynchronization therapy.

Michael R Gold1, Yinghong Yu2, Nicholas Wold2, John D Day3.   

Abstract

BACKGROUND: Pacing at sites with late electrical activation or greater interventricular delay is associated with improvement in measures of cardiac resynchronization therapy (CRT) response, primarily reverse remodeling. However, little is known about whether such lead positions improve heart failure (HF) clinical outcomes.
OBJECTIVE: The purpose of this study was to assess the association between interventricular electrical delay and HF clinical outcomes.
METHODS: The Pacing Evaluation-Atrial SUpport Study was a multicenter randomized trial of patients undergoing CRT-defibrillator implantation. Interventricular delay was measured as the unpaced right ventricle-left ventricle (RV-LV) interval in sinus rhythm. The HF clinical composite score was the primary end point. In addition, the time to first HF hospitalization or death was measured and events were adjudicated by a blinded core laboratory. The cohort was divided at the median RV-LV interval into short (<67 ms) and long (≥67 ms) subgroups. In addition, receiver operating characteristic curves were constructed to identify the optimal cutoff of the RV-LV interval and spline analysis was performed to assess RV-LV interval as a continuous variable.
RESULTS: A total of 1342 patients were included in this study. The clinical composite score at 1 year differed between groups, with more patients improving and fewer patients worsening in the long RV-LV group (P = .014). The time to first HF hospitalization or mortality also differed with a lower risk of an event in the long RV-LV group (hazard ratio 0.62; P = .002). Multivariate analysis showed that RV-LV time (hazard ratio 0.71; P = .038) and sex were independent predictors of this outcome.
CONCLUSION: Baseline interventricular delay is a strong independent predictor of clinical response to CRT.
Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac resynchronization therapy; Heart failure; Interventricular delay; Outcomes; Pacing

Mesh:

Year:  2017        PMID: 29195547     DOI: 10.1016/j.hrthm.2017.10.016

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  7 in total

1.  Non-invasively quantified changes in left ventricular activation predict outcomes in patients undergoing cardiac resynchronization therapy.

Authors:  Daniel J Friedman; Kasper Emerek; Steen Møller Hansen; Christoffer Polcwiartek; Peter L Sørensen; Zak Loring; Joanne Sutter; Peter Søgaard; Joseph Kisslo; Claus Graff; Brett D Atwater
Journal:  J Cardiovasc Electrophysiol       Date:  2019-10-08

2.  Changes in cardiac conduction time following cardiac resynchronization therapy: rationale and design of the RECOVER study.

Authors:  Hye Bin Gwag; June Soo Kim; Kyoung-Min Park; Young Keun On; Seung-Jung Park
Journal:  J Interv Card Electrophysiol       Date:  2021-03-27       Impact factor: 1.900

3.  The relationship between ECG predictors of cardiac resynchronization therapy benefit.

Authors:  Josef Halamek; Pavel Leinveber; Ivo Viscor; Radovan Smisek; Filip Plesinger; Vlastimil Vondra; Jolana Lipoldova; Magdalena Matejkova; Pavel Jurak
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

4.  Intracardiac conduction time as a predictor of cardiac resynchronization therapy response: Results of the BIO|SELECT pilot study.

Authors:  Kyoko Soejima; Yusuke Kondo; Shingo Sasaki; Kazumasa Adachi; Ritsushi Kato; Nobuhisa Hagiwara; Tomoo Harada; Kengo Kusano; Fumiharu Miura; Itsuro Morishima; Kazuyasu Yoshitani; Akihiko Yotsukura; Manabu Fujimoto; Nobuhiro Nishii; Kenji Shimeno; Masatsugu Ohe; Hiroshi Tasaka; Hiroto Sasaki; Juergen Schrader; Kenji Ando
Journal:  Heart Rhythm O2       Date:  2021-09-28

5.  Novel electrocardiographic dyssynchrony criteria that may improve patient selection for cardiac resynchronization therapy.

Authors:  Gábor Katona; András Vereckei
Journal:  J Geriatr Cardiol       Date:  2022-01-28       Impact factor: 3.327

6.  Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization Therapy.

Authors:  Michael R Gold; Yinghong Yu; Jagmeet P Singh; Ulrika Birgersdotter-Green; Kenneth M Stein; Nicholas Wold; Timothy E Meyer; Kenneth A Ellenbogen
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-08

7.  Lateral left ventricular lead position is superior to posterior position in long-term outcome of patients who underwent cardiac resynchronization therapy.

Authors:  Anett Behon; Walter Richard Schwertner; Eperke Dóra Merkel; Attila Kovács; Bálint Károly Lakatos; Endre Zima; László Gellér; Valentina Kutyifa; Annamária Kosztin; Béla Merkely
Journal:  ESC Heart Fail       Date:  2020-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.